Omega-3 Treatment for Concussion in Adolescents (CONCUSS)
Concussion, Mild
About this trial
This is an interventional treatment trial for Concussion, Mild focused on measuring Omega-3
Eligibility Criteria
Inclusion Criteria: Provide a signed and dated informed consent form; State their willingness to comply with all study procedures and availability for the duration of the study; Be between 14 and 17 years of age or older; Meet the diagnostic criteria of a concussion set forth by the Consensus Statement on Concussion in Sport 5th Annual Conference of Concussion in Sport, 2017 as determined by the treating physician; Present with a sport related concussion within 7 days from injury; and Assigned a Glasgow coma scale (GCS) score = 15. Exclusion Criteria: Patients with a history of moderate or severe traumatic brain injury, epilepsy, or stroke; Patients who have been diagnosed with a skull fracture, traumatic subarachnoid hemorrhage, subdural hematoma, epidural hematoma, intraparenchymal hemorrhage or cerebral contusion on previous neuro-imaging studies; Pregnant patients; Patients with a GCS score less than or equal to 14; Patients for whom parental/guardian consent cannot be obtained; Patients who have consumed an omega-3 fatty acid containing supplement within the past month; Patients with a fish or shell fish allergy.
Sites / Locations
- Applied Research Centre, Faculty of Kinesiology, University of Manitoba
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Omega-3 Supplementation
Placebo
This groups will supplement their regular diet with 1 tsp of fish oil containing 1.5 grams combined omega-3 fatty acid (EPA/DHA) supplement in liquid form on a daily basis until they are recovered or have been enrolled for 6 weeks.
This group will supplement their regular diet with 1 tsp olive oil in liquid form on a daily basis until they are recovered or have been enrolled for 6 weeks.